Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration

Neurochemistry International

Volumn 40, Issue 1, 2002, Pages 69-78

  Citron, Bruce A ^a,b   Suo, Zhiming ^a,b   SantaCruz, Karen ^b   Davies, Peter J A ^c   Qin, Frank ^a   Festoff, Barry W ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Central nervous system; G protein; Peripheral nervous system; Transglutaminase

Indexed keywords

BRAIN ENZYME; DIPEPTIDE; GLUTAMINE DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOENZYME; LYSINE; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; REPETITIVE DNA;

AGED; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; APOPTOSIS; BRAIN REGION; CATALYSIS; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CONTROLLED STUDY; COVALENT BOND; ENZYME ACTIVITY; EPIDERMIS CELL; FIBRIN CLOT; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MOLECULAR SIZE; MULTIGENE FAMILY; NERVE DEGENERATION; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN VARIANT; SIGNAL TRANSDUCTION; SKIN PROTECTION;

AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; ALZHEIMER DISEASE; BRAIN; DNA, COMPLEMENTARY; HUMANS; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; RNA, MESSENGER; SYNUCLEINS; TRANSGLUTAMINASES;

EID: 0036135523     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(01)00062-6     Document Type: Conference Paper

References (72)

1. Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity
2. Immunochemical analyses of human plasma fibronectin-cytosolic transglutaminase interactions
3. Selective alterations in transglutaminase activity of rat superior cervical ganglia in response to neurotransmitters, high potassium and sialic acid-containing compounds
4. Localization of transglutaminase in hippocampal neurons: Implications for Alzheimer's disease
5. Neural apoptosis
6. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
7. Conformational disease
8. Conformational changes and disease - Serpins, prions and Alzheimer's
9. The structural basis for the regulation of tissue transglutaminase by calcium ions
10. Role of the proteasome in Alzheimer's disease
11. Tissue transglutaminase: An enzyme with a split personality
12. Alpha1-adrenergic receptor signaling via Gh is subtype specific and independent of its transglutaminase activity
13. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
14. Regulation of the dual function tissue transglutaminase/Gαh during murine neuromuscular development: Gene and enzyme isoform expression
15. Intron-exon swapping of transglutaminase mRNA and neuronal tau aggregation in Alzheimer's disease
16. Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability
17. Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60) cells
18. Retinoids as generalized regulators of cellular growth and differentiation
19. A comprehensive set of sequence analysis programs for the VAX
20. Retinoic acid receptor gamma1 (RARgamma1) levels control RARbeta2 expression in SK-N-BE2(c) neuroblastoma cells and regulate a differentiation-apoptosis switch
21. Transglutaminase induction by various cell death and apoptosis pathways
22. A third human tissue transglutaminase homologue as a result of alternative gene transcripts
23. Organization and structure of the human tissue transglutaminase gene
24. Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases
25. Structural and functional differences between 3-repeat and 4-repeat tau isoforms. Implications for normal tau function and the onset of neurodegenerative disease
26. Cross-linking of beta-amyloid protein precursor catalyzed by tissue transglutaminase
27. RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells
28. Interaction site of GTP binding Gh (transglutaminase II) with phospholipase C
29. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease
30. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP
31. GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket
32. Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer/A4 amyloid protein by transglutaminase
33. Increase caused by interleukin-6 in promoter activity of guinea pig liver transglutaminase gene
34. Transglutaminase II: A new class of GTP-binding protein with new biological functions
35. Abundant expression and cytoplasmic aggregations of [alpha]1A voltage- dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6
36. Neuropathology of Alzheimer's disease: A critical update
37. Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide
38. Transglutaminase activity is increased in Alzheimer's disease brain
39. Aggresomes: A cellular response to misfolded proteins
40. Impaired proteasome function in Alzheimer's disease
41. Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease
42. Conformational disease
43. Induction of apoptosis by all-trans retinoic acid in the human myeloma cell line RPMI 8226 and negative regulation of some of its typical morphological features by dexamethasone
44. Transglutaminases
45. Characteristics of cyclic AMP enhancement of retinoic acid induction of increased transglutaminase activity in HL60 cells
46. Ubiquitin and the molecular pathology of chronic degenerative diseases
47. Endosome-lysosomes, ubiquitin and neurodegeneration
48. Commentary on the consensus recommendations for the post mortem diagnosis of Alzheimer's disease
49. Retinoic acid receptors alpha and gamma mediate the induction of "tissue" transglutaminase activity and apoptosis in human neuroblastoma cells
50. The importance of the GTP-binding protein tissue transglutaminase in the regulation of cell cycle progression
51. Expression of GTP-dependent and GTP-independent tissue-type transglutaminase in cytokine-treated rat brain astrocytes
52. GTP-dependent conformational changes associated with the functional switch between G-alpha and cross-linking activities in brain-derived tissue transglutaminase
53. Cyclic AMP potentiates the retinoic acid-induced expression of tissue transglutaminase in peritoneal macrophages
54. Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter
55. Gh: A GTP-binding protein with transglutaminase activity and receptor signaling function
56. Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease
57. Use of image analysis to quantitate changes in form of mitochondrial DNA after X-irradiation
58. Identification of glutamine and lysine residues in Alzheimer amyloid beta A4 peptide responsible for transglutaminase-catalysed homopolymerization and cross-linking to alpha 2M receptor
59. Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2)
60. Mechanisms of tumor necrosis factor action
61. Brain transglutaminase: In vitro crosslinking of human neurofilament proteins into insoluble polymers
62. Measurement of protein using bicinchoninic acid
63. In vivo evidence of potential pathogenetic role of tissue transglutaminase (tTG) in Lewy body (LB) formation and neuronal degeneration
64. Expression induced by interleukin-6 of tissue-type transglutaminase in human hepatoblastoma HepG2 cells
65. Tumour necrosis factor alpha and interleukin-1 beta induce specific subunits of NFKB to bind the HIV-1 enhancer: Characterisation of transcription factors controlling human immunodeficiency virus type 1 gene expression in neural cells
66. Active cell death in hormone-dependent tissues
67. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease
68. Retinoic acid induction of the tissue transglutaminase promoter is mediated by a novel response element
69. Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy
70. Evidence for the involvement of retinoic acid receptor RAR alpha- dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids
71. Immunohistochemical demonstration of tissue transglutaminase in amyloid plaques